Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-26

Clinical Trial Update: Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine [Phase 4]

View source ↗

Summary

Phase 4 trial updating post-cesarean analgesia using epidural morphine after epidural 2-chloroprocaine has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Physiological Effect of Drugs, Morphine | Phase 4 | Status: COMPLETED | Results posted: 2022-05-26